NRAS Gene Complete Identifier and Functional Mapping Reference

Provide a comprehensive cross-database identifier and functional mapping reference for human NRAS. This should serve as a definitive lookup resource …

Provide a comprehensive cross-database identifier and functional mapping reference for human NRAS. This should serve as a definitive lookup resource for researchers. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 1: GENE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Provide ALL gene-level database identifiers: - HGNC ID and approved symbol - Ensembl gene ID (ENSG) - NCBI Entrez Gene ID - OMIM gene/locus ID - Genomic location: chromosome, start position, end position, strand ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 2: TRANSCRIPT IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL transcript-level identifiers: - Ensembl transcripts: ALL ENST IDs with biotype (protein_coding, etc.) How many total transcripts? - RefSeq transcripts: ALL NM_ mRNA accessions Mark which is MANE Select (canonical clinical standard) - CCDS IDs: ALL consensus coding sequence identifiers For the CANONICAL/MANE SELECT transcript: - List ALL exon IDs (ENSE) with genomic coordinates - Total exon count ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 3: PROTEIN IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL protein-level identifiers: - UniProt accessions: ALL entries (reviewed and unreviewed) Mark the canonical reviewed entry - RefSeq protein: ALL NP_ accessions Protein domains and families: - List ALL annotated domains/families with identifiers - Include: domain name, type (domain/family/superfamily), and ID ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 4: STRUCTURE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Experimental structures: - List ALL PDB structure IDs - For each: experimental method (X-ray, NMR, Cryo-EM) and resolution - Total PDB structure count Predicted structures: - AlphaFold model ID and confidence metrics (pLDDT) ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 5: CROSS-SPECIES ORTHOLOGS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List orthologous genes in key model organisms (where available): - Mouse (Mus musculus): gene ID, symbol - Rat (Rattus norvegicus): gene ID, symbol - Zebrafish (Danio rerio): gene ID, symbol - Fruit fly (Drosophila melanogaster): gene ID, symbol - Worm (C. elegans): gene ID, symbol - Yeast (S. cerevisiae): gene ID, symbol ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 6: CLINICAL VARIANTS & AI PREDICTIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Clinical variant annotations: - Total variant count in clinical databases - Breakdown by classification: Pathogenic, Likely Pathogenic, Uncertain Significance (VUS), Likely Benign, Benign - List TOP 50 pathogenic/likely pathogenic variants with: variant ID, HGVS notation, associated condition AI-based variant effect predictions: - Splice effect predictions: Total count List TOP 50 predicted splice-altering variants with delta scores - Missense pathogenicity predictions: Total count List TOP 50 predicted pathogenic missense variants with scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 7: BIOLOGICAL PATHWAYS & GENE ONTOLOGY ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Pathway membership: - List ALL biological pathways this gene participates in - Include pathway IDs and names - Total pathway count Gene Ontology annotations: - Biological Process: count and TOP 20 terms with IDs - Molecular Function: count and TOP 20 terms with IDs - Cellular Component: count and TOP 20 terms with IDs ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 8: PROTEIN INTERACTIONS & MOLECULAR NETWORKS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Protein-protein interactions: - Total interaction count - List TOP 50 highest-confidence interacting proteins with scores Protein similarity (evolutionary and structural): - Structural/embedding similarity: How many similar proteins? List TOP 20 with similarity scores - Sequence homology: How many homologous proteins? List TOP 20 with identity/similarity scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 9: TRANSCRIPTION FACTOR REGULATORY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene encodes a transcription factor: Downstream targets (genes regulated BY this TF): - Total target gene count - List TOP 50 target genes with regulation type (activates/represses) DNA binding profiles: - List ALL known binding motif IDs - Motif family classification Upstream regulators (TFs that regulate THIS gene): - List known transcriptional regulators with evidence type ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 10: DRUG & PHARMACOLOGY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene/protein is a drug target: Targeting molecules: - How many drug/compound molecules target this protein? - List TOP 30 molecules by development phase - Include: molecule ID, name, mechanism, highest development phase Clinical trials: - How many clinical trials involve drugs targeting this gene? - List TOP 20 trials with: trial ID, phase, status, intervention Pharmacogenomics: - Known drug-gene interactions affecting drug response - Dosing guidelines if any exist ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 11: EXPRESSION PROFILES ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Tissue expression: - Which tissues express this gene most highly? - List TOP 30 tissues with expression scores/levels - Note any tissue-specific or tissue-enriched patterns Cell type expression: - Which cell types show highest expression? - List TOP 30 cell types with expression scores - Note any cell type-specific patterns Single-cell expression data (if available): - Which single-cell datasets/experiments include this gene? - Notable cell population patterns ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 12: DISEASE ASSOCIATIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Mendelian/monogenic disease links: - What diseases are caused by mutations in this gene? - List ALL associated diseases with: disease name, disease ID, inheritance pattern, evidence level Phenotype associations: - What clinical phenotypes are associated with this gene? - List TOP 50 phenotype terms with IDs Complex trait associations (GWAS): - What traits/diseases are linked via genome-wide association studies? - List TOP 30 GWAS associations with: trait, study ID, p-value, effect size if available ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ FORMATTING REQUIREMENTS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ - Present each section with clear headers - Use tables for listing multiple items - Always include COUNTS for every category - For lists with >50 items: show total count + TOP 50 - For lists with <50 items: show ALL items - Always include database identifiers (IDs), not just names - Mark canonical/primary/reviewed entries where applicable - If a section has no data available, state "No data available" rather than omitting the section

Structured Data Sources

This answer was generated using Claude Opus 4.5 + BioBTree MCP, querying 35 biological databases.

Further analyze this answer or run your own queries with BioBTree MCP.

Datasets: alphafold, alphamissense, bgee, bgee_evidence, biogrid_interaction, ccds, chembl_molecule, chembl_target, clinvar, collectri, diamond_similarity, ensembl, entrez, esm2_similarity, exon, gencc, go, gwas, hgnc, hpo, intact, interpro, mim, orphanet, ortholog, pdb, pfam, pharmgkb_gene, reactome, refseq, signor, spliceai, string_interaction, transcript, uniprot
Generated: 2026-03-27 — For the latest data, query BioBTree directly via MCP or API.
View API calls (45)
NRAS

Section 1: Gene Identifiers

DatabaseIdentifierDetails
HGNCHGNC:7989Approved symbol: NRAS
Full NameNRAS proto-oncogene, GTPase
Ensembl GeneENSG00000213281
NCBI Entrez Gene4893
OMIM164790Gene/locus
COSMICNRAS(via HGNC)
VEGA(linked)(via HGNC)
Genomic Location:
AttributeValue
Chromosome1
Cytogenetic Band1p13.2
Start Position114,704,468
End Position114,716,770
StrandMinus (-)
Genome AssemblyGRCh38
Genomic AccessionNC_000001.11
Gene Classification:
  • Locus Group: protein-coding gene
  • Locus Type: gene with protein product
  • Gene Family: RAS type GTPase family
  • Status: Approved Aliases & Previous Names:
- Aliases- Previous NamesTotal Ensembl Transcripts
N-ras, ALPS4, CMNS, NCMS, NRAS1, NS6neuroblastoma RAS viral (v-ras) oncogene homolog
Transcript Identifiers**4
Transcript IDBiotypeStartEndUTR5UTR3
ENST00000369535 ★protein_coding114,704,469114,716,771114,716,658-114,716,771114,708,531-114,708,534
ENST00000899430protein_coding114,704,471114,716,756114,716,658-114,716,756114,708,531-114,708,534
ENST00000931009protein_coding114,704,469114,716,747114,716,658-114,716,747114,708,531-114,708,534
ENST00000931010protein_coding114,704,472114,716,640114,716,531-114,716,640114,708,531-114,708,534
★ = Canonical transcript RefSeq Transcripts (Human):
RefSeq IDTypeStatusMANE Select
NM_002524mRNAREVIEWED★ YES
NP_002515proteinREVIEWED★ YES
CCDS ID: CCDS877 Exons for Canonical Transcript (ENST00000369535): Total Exon Count: 7
Exon IDStartEndStrand
ENSE00001364464114,716,658114,716,771-
ENSE00001450282114,716,050114,716,177-
ENSE00001751295114,713,800114,713,978-
ENSE00000784343114,709,569114,709,728-
ENSE00000800104114,708,531114,708,654-
ENSE00001365300114,708,154114,708,192-
ENSE00001450280114,704,469114,708,050-

Section 3: Protein Identifiers UniProt Accessions:

AccessionNameStatusLengthMass
P01111 ★GTPase NRasReviewed (Swiss-Prot)189 aa21,229 Da
Q5U091GTPase NRasUnreviewed (TrEMBL)--
★ = Canonical reviewed entry Alternative Names: Transforming protein N-Ras RefSeq Protein: NP_002515 (MANE Select) Protein Domains and Families:
DatabaseIDNameType
InterProIPR001806Small_GTPaseFamily
InterProIPR005225Small_GTP-bdDomain
InterProIPR020849Small_GTPase_Ras-typeFamily
InterProIPR027417P-loop_NTPaseHomologous_superfamily
PfamPF00071Ras familyDomain
PANTHER(linked)
SUPFAM(linked)
CDD(linked)
SMART(3 entries)
CATH-Gene3D(linked)

Section 4: Structure Identifiers Total PDB Structures: 29

PDB IDTitleMethodResolution (Å)
9BG8Daraxonrasib/NRAS Q61R/CypA complexX-RAY1.20
7F68NRAS S89D crystal structureX-RAY1.24
9BG3Daraxonrasib/NRAS Q61K/CypA complexX-RAY1.33
6ZIONRAS (C118S) with GDPX-RAY1.55
8TBIRMC-7977/NRAS WT/CypA tricomplexX-RAY1.59
9BG0Daraxonrasib/NRAS WT/CypA tricomplexX-RAY1.64
6WGHGDP-bound NRAS with ITDX-RAY1.65
3CONHuman NRAS GTPase with GDPX-RAY1.65
5UHVWild-type NRas with GppNHpX-RAY1.67
8VM2NRAS Q61K with GTPX-RAY1.74
9BGDDaraxonrasib/NRAS Q61L/CypA complexX-RAY1.76
6ZIZNRAS Q61R with GTP and compound 18X-RAY1.79
7OW4HLA-A*11:01 with KRAS G12D peptideX-RAY1.81
9GLXNRas-Q61R-GTP with peptide MPB3X-RAY1.85
6ULITCR/HLA-A*11:01/KRAS-G12DX-RAY1.88
6ZIRNRAS (C118S) with GDP/compound 18X-RAY1.90
6ULKTCR/HLA-A*11:01/KRAS-G12DX-RAY1.90
6E6HNRAS G13D with GppNHpX-RAY1.99
6ULNTCR/HLA-A*11:01/KRAS-G12DX-RAY2.01
9GLWNRas-Q61R-GTP with peptide MPB2X-RAY2.10
7OW3HLA-A*11:01 with KRAS peptideX-RAY2.46
7OW5TCR/HLA-A*11:01/KRAS peptideX-RAY2.58
7OW6TCR/HLA-A*11:01/KRAS G12D peptideX-RAY2.64
9BTMNRas Q61R with Shoc2X-RAY2.73
6ULRTCR/HLA-A*11:01/KRAS-G12DX-RAY3.20
7PB2JDI TCR/HLA-A*11:01/KRAS G12DX-RAY3.41
6UONTCR/HLA-A*11:01/KRAS-G12DX-RAY3.50
2N9CNRAS Isoform 5SOLUTION NMR-
6MPPHLA-A*01:01/NRAS Q61K peptideSOLUTION NMR-
AlphaFold Predicted Structure:
EntrypLDDT ScoreSequence LengthFraction Very High Confidence
AF-P0111192.561484*0.81 (81%)
*Note
AlphaFold model includes full-length isoform
Cross-Species Orthologs**
OrganismGene IDSymbolType
Mouse (Mus musculus)ENSMUSG00000027852Nrasprotein_coding
Rat (Rattus norvegicus)ENSRNOG00000023079Krasprotein_coding
Zebrafish (Danio rerio)ENSDARG00000038225nrasprotein_coding
Fruit fly (Drosophila)No direct ortholog-(see paralogs)
C. elegansNo direct ortholog-(RAS pathway conserved)
S. cerevisiaeNo direct ortholog-(RAS1/RAS2 functional analogs)
Total paralogs in human
35 (RAS family members including HRAS, KRAS)
Clinical Variants & AI Predictions**
ClinVar Variants Total ClinVar Variants: 330 Classification Breakdown:
ClassificationCount
Pathogenic10
Likely pathogenic10
Pathogenic/Likely pathogenic2
Uncertain significance (VUS)~150
Conflicting classifications~20
Likely benign~100
Benign~10
Benign/Likely benign~5
Pathogenic Variants (10 total)
Variant IDHGVS NotationProtein ChangeReview Status
177778c.34G>Ap.Gly12SerReviewed by expert panel
40468c.34G>Tp.Gly12CysCriteria provided
40469c.34G>Cp.Gly12ArgMultiple submitters
13900c.182A>Gp.Gln61ArgMultiple submitters
280409c.182A>Cp.Gln61ProSingle submitter
13902c.149C>Tp.Thr50IleReviewed by expert panel
13903c.179G>Ap.Gly60GluReviewed by expert panel
1070042c.173C>Tp.Thr58IleReviewed by expert panel
39647c.101C>Tp.Pro34LeuNo criteria
40472c.112-1_113dupSplice siteSingle submitter
Likely Pathogenic Variants (10 total)
Variant IDHGVS NotationProtein ChangeReview Status
13899c.37G>Cp.Gly13ArgMultiple submitters
375876c.38G>Tp.Gly13ValSingle submitter
222971c.71T>Ap.Ile24AsnReviewed by expert panel
1335888c.108A>Gp.Ile36MetSingle submitter
812886c.176C>Ap.Ala59AspNo criteria
561786c.178G>Ap.Gly60ArgMultiple submitters
981556c.204A>Tp.Arg68SerNo criteria
1320232c.449A>Gp.Gln150ArgSingle submitter
2672090c.191_196dupp.Ser65_Ala66insAspSerSingle submitter
3029607c.34_35delinsTTp.Gly12PheNo criteria
SpliceAI Predictions Total Splice Predictions: 577 TOP 50 High-Impact Splice-Altering Variants:
VariantEffectDelta Score
1:114707945:TAAAC:Tdonor_gain1.00
1:114707948:A:Cdonor_gain0.99
1:114708048:CAGCT:Cacceptor_loss0.99
1:114708049:AGCTG:Aacceptor_loss0.99
1:114708050:GCTGA:Gacceptor_loss0.99
1:114708046:TGCAG:Tacceptor_gain0.99
1:114708051:CTG:Cacceptor_loss0.99
1:114708052:T:Aacceptor_loss0.99
1:114708047:GCAG:Gacceptor_gain0.98
1:114708048:CAG:Cacceptor_gain0.99
1:114708150:CTA:Cdonor_loss0.98
1:114708151:TACCT:Tdonor_loss0.98
1:114708153:C:Gdonor_loss0.98
1:114708051:C:CCacceptor_gain0.98
1:114707949:C:CTdonor_gain0.97
1:114707950:T:TTdonor_gain0.97
1:114708056:A:ACacceptor_gain0.97
1:114708153:CCT:Cacceptor_loss0.97
1:114708189:GTAT:Gacceptor_gain0.97
1:114708154:C:Aacceptor_loss0.96
1:114708152:ACCTT:Aacceptor_loss0.96
1:114707979:T:TAdonor_gain0.95
1:114708149:CCTA:Cacceptor_loss0.95
1:114708150:CTAC:Cacceptor_loss0.95
1:114707951:A:ACdonor_gain0.94
1:114707952:C:CCdonor_gain0.94
1:114708013:T:TAdonor_gain0.94
1:114708049:A:Tacceptor_gain0.94
1:114708151:TACC:Tacceptor_loss0.94
1:114708148:TCCTA:Tacceptor_loss0.92
1:114708189:GTATC:Gdonor_loss0.92
1:114707944:CTAAA:Cdonor_gain0.90
1:114708188:AGTAT:Aacceptor_gain0.86
1:114708064:A:Tacceptor_gain0.82
1:114708147:GTCCT:Gacceptor_loss0.82
1:114705423:T:Gacceptor_gain0.80
1:114708056:A:Cacceptor_gain0.79
1:114707946:A:Tdonor_gain0.78
1:114708063:C:CTacceptor_gain0.76
1:114708155:TTGA:Tdonor_loss0.54
(showing top 40 with delta score ≥0.54)
AlphaMissense Predictions Total AlphaMissense Predictions: 1,251 TOP 50 Predicted Pathogenic Missense Variants:
VariantProtein ChangeAM ScoreClass
1:114709582:G:TA146D1.000likely_pathogenic
1:114709586:A:GS145P1.000likely_pathogenic
1:114708637:A:CF156L0.999likely_pathogenic
1:114708637:A:TF156L0.999likely_pathogenic
1:114708629:A:GL159P0.999likely_pathogenic
1:114708638:A:GF156S0.998likely_pathogenic
1:114709585:G:AS145L0.998likely_pathogenic
1:114708614:C:GR164P0.998likely_pathogenic
1:114708626:A:TV160E0.997likely_pathogenic
1:114709578:C:AK147N0.997likely_pathogenic
1:114709582:G:AA146V0.996likely_pathogenic
1:114708629:A:CL159R0.996likely_pathogenic
1:114708629:A:TL159Q0.996likely_pathogenic
1:114708651:C:AV152F0.996likely_pathogenic
1:114709617:A:TI163K0.995likely_pathogenic
1:114709580:T:CK147E0.994likely_pathogenic
1:114709583:C:TA146T0.994likely_pathogenic
1:114709573:C:AR149I0.993likely_pathogenic
1:114708617:A:CI163R0.992likely_pathogenic
1:114708638:A:CF156C0.991likely_pathogenic
1:114709579:T:GK147T0.990likely_pathogenic
1:114708622:T:AR161S0.989likely_pathogenic
1:114708623:C:AR161I0.989likely_pathogenic
1:114709596:G:AT144I0.989likely_pathogenic
1:114708642:C:GA155P0.988likely_pathogenic
1:114708651:C:GV152L0.987likely_pathogenic
1:114708639:A:TF156I0.987likely_pathogenic
1:114708617:A:GI163T0.985likely_pathogenic
1:114708615:G:TR164S0.984likely_pathogenic
1:114709573:C:GR149T0.983likely_pathogenic
1:114709596:G:TT144N0.982likely_pathogenic
1:114708623:C:GR161T0.980likely_pathogenic
1:114708650:A:GV152A0.980likely_pathogenic
1:114708639:A:CF156V0.977likely_pathogenic
1:114708614:C:AR164L0.937likely_pathogenic
1:114708627:C:AV160L0.971likely_pathogenic
1:114708605:C:GR167P0.971likely_pathogenic
1:114709577:T:GT148P0.970likely_pathogenic
1:114708624:T:CR161G0.967likely_pathogenic
1:114709570:T:GQ150P0.965likely_pathogenic
1:114708615:G:CR164G0.963likely_pathogenic
1:114709572:T:AR149S0.963likely_pathogenic
1:114708650:A:CV152G0.960likely_pathogenic
1:114708653:C:AG151V0.948likely_pathogenic
1:114709579:T:AK147M0.945likely_pathogenic
1:114708648:C:TE153K0.944likely_pathogenic
1:114708633:T:GT158P0.941likely_pathogenic
1:114708626:A:CV160G0.941likely_pathogenic
1:114708626:A:GV160A0.938likely_pathogenic
1:114709580:T:GK147Q0.933likely_pathogenic

Section 7: Biological Pathways & Gene Ontology Reactome Pathways Total Pathways: 68

Pathway IDPathway NameDisease Pathway
R-HSA-9753512Signaling by RAS GTPase mutantsYes
R-HSA-9649948Signaling downstream of RAS mutantsYes
R-HSA-9648002RAS processingNo
R-HSA-5658442Regulation of RAS by GAPsNo
R-HSA-5673001RAF/MAP kinase cascadeNo
R-HSA-5673000RAF activationNo
R-HSA-5674135MAP2K and MAPK activationNo
R-HSA-167044Signalling to RASNo
R-HSA-112412SOS-mediated signallingNo
R-HSA-6802946Signaling by moderate kinase activity BRAF mutantsYes
R-HSA-6802948Signaling by high-kinase activity BRAF mutantsYes
R-HSA-6802952Signaling by BRAF and RAF1 fusionsYes
R-HSA-6802953RAS signaling downstream of NF1 loss-of-functionYes
R-HSA-6802955Paradoxical RAF activation by kinase inactive BRAFYes
R-HSA-9656223Signaling by RAF1 mutantsYes
R-HSA-9753510Signaling by RAS GAP mutantsYes
R-HSA-1236382Constitutive Signaling by EGFR Cancer VariantsYes
R-HSA-5637810Constitutive Signaling by EGFRvIIIYes
R-HSA-9634285Constitutive Signaling by Overexpressed ERBB2Yes
R-HSA-1169092Activation of RAS in B cellsNo
R-HSA-171007p38MAPK eventsNo
R-HSA-000165MAPK cascadeNo
R-HSA-179812GRB2 events in EGFR signalingNo
R-HSA-180336SHC1 events in EGFR signalingNo
R-HSA-186763Downstream signal transductionNo
R-HSA-5675221Negative regulation of MAPK pathwayNo
R-HSA-6798695Neutrophil degranulationNo
R-HSA-74751Insulin receptor signalling cascadeNo
R-HSA-8851805MET activates RAS signalingNo
R-HSA-9027284Erythropoietin activates RASNo
R-HSA-9607240FLT3 SignalingNo
R-HSA-210993Tie2 SignalingNo
R-HSA-375165NCAM signaling for neurite out-growthNo
R-HSA-442982Ras activation upon Ca2+ influx through NMDA receptorNo
R-HSA-5218921VEGFR2 mediated cell proliferationNo
R-HSA-5621575CD209 (DC-SIGN) signalingNo
(and 32 more pathways...)
Gene Ontology Annotations Total GO Terms: 16 Biological Process (4):
GO IDTerm
GO:0007265Ras protein signal transduction
GO:0000165MAPK cascade
GO:0001938positive regulation of endothelial cell proliferation
Molecular Function (5):
GO IDTerm
GO:0003924GTPase activity
GO:0003925G protein activity
GO:0005525GTP binding
GO:0019003GDP binding
GO:0044877protein-containing complex binding
Cellular Component (8):
GO IDTerm
GO:0005886plasma membrane
GO:0005829cytosol
GO:0005794Golgi apparatus
GO:0000139Golgi membrane
GO:0005789endoplasmic reticulum membrane
GO:0016020membrane
GO:0070062extracellular exosome
GO:0070821tertiary granule membrane

Section 8: Protein Interactions & Molecular Networks STRING Protein-Protein Interactions Total STRING Interactions: 6,520+ TOP 50 Highest-Confidence Interacting Proteins:

UniProtGeneScore
P15056BRAF973
P42336PIK3CA921
Q9Y397PREX1901
P00533EGFR900
P04049RAF1900
Q06124PTPN11892
Q07889SOS1887
P07557BMX886
P21359NF1886
P04637TP53871
P48736PIK3CG870
P60484PTEN861
Q7Z5G4RASGRP4860
Q9UM73ALK854
Q12967DAB2846
P42771CDKN2A838
P06748NPM1823
Q02750MAP2K1814
P10721KIT813
Q9UQ13LZTR1812
P22607FGFR3806
Q06710PAX3803
P36888FLT3794
P29992GNA11790
P04626ERBB2788
Q15910EZH2788
Q8IXJ9SASH1782
P24385CCND1781
P07949RET777
P19544WT1774
P31749AKT1774
O75874IDH1773
P11802CDK4771
P18443SOS2767
Q6N021RHOD765
P20936RASA1764
P48735IDH2764
P10415BCL2763
P50148GNAQ747
Q01196RUNX1727
Q9Y6K1PDPK1724
Q01081U2AF1712
P08922ROS1705
Q969H0FBXW7701
Q01130SRSF2697
P04198MYCN685
O60674JAK2683
O75534CSDE1677
P35222CTNNB1676
O14746TERT675
BioGRID Interactions Total BioGRID Interactions: 914 Key Interactors by Experimental System:
InteractorExperimental System
RAF1Affinity Capture-Western, Synthetic Lethality
BRAFAffinity Capture-Western, Two-hybrid
MAP2K7Affinity Capture-Western
LZTR1Affinity Capture-Western, Luminescence, Co-localization
CBLAffinity Capture-MS, Affinity Capture-Western
RAP1GDS1Two-hybrid
RCE1Synthetic Lethality
ICMTSynthetic Lethality
SHOC2Synthetic Lethality
PREX1Synthetic Lethality
GOLGA7Synthetic Lethality
GRB2Proximity Label-MS
ROCK1/2Proximity Label-MS
PI4KAProximity Label-MS
RICTORProximity Label-MS
BTKProximity Label-MS
AKT pathwayMultiple
IntAct Interactions Total IntAct Interactions: 160 Highest Confidence Interactions:
Interaction IDPartnerScoreType
EBI-15716891RAF10.930physical association
EBI-24691741RAF10.930physical association
EBI-44458443RAF10.930association
EBI-15920564BRAF0.860physical association
EBI-28931955BRAF0.860association
EBI-32717084BRAF0.860physical association
EBI-24445028RIN10.840physical association
EBI-25265548ARAF0.560physical association
EBI-25882313PIK3R10.560physical association
EBI-24552005RAP1GDS10.560physical association
EBI-24713213RGL30.560physical association
EBI-21916458FNTA0.560physical association
EBI-3932755RGL20.550physical association
Protein Similarity ESM2 Structural/Embedding Similarity: Total Similar Proteins: 74
UniProtTop SimilarityAvg Similarity
P011111.00000.9941
P08556 (Bovine NRAS)0.99980.9942
Q04970 (Rat NRAS)0.99990.9942
Q95ME4 (Pig NRAS)0.99980.9941
P01112 (HRAS)1.00000.9932
P01116 (KRAS)0.99990.9933
P011130.99890.9925
P61223 (RAP1B)1.00000.9907
P62833-6 (RAP2 family)1.00000.9898
DIAMOND Sequence Similarity: Total Homologous Proteins: 168+
UniProtGeneIdentity (%)Bitscore
P01111NRAS100.00379
P01112HRAS100.00383
P01116KRAS99.00372
P08642100.00378
P62070/P62071RRAS2100.00399
P08556Bovine NRAS98.40375
P1282599.50379
P3686098.50385

Section 9: Transcription Factor Regulatory Data Note: NRAS is NOT a transcription factor; it is a GTPase signaling protein. Upstream Transcriptional Regulators of NRAS CollecTRI Data (TFs regulating NRAS):

TF GeneRegulationConfidence
AR (Androgen Receptor)Repression-
MYBRepressionHigh
MYCUnknownHigh
NR1H2 (LXRβ)-High
SIGNOR Signaling Interactions Upstream Regulators of NRAS Activity:
RegulatorEffectMechanismDirectScore
SOS1up-regulates activityGEFYes0.78
RASGEF1Aup-regulatesbindingYes0.39
RASGEF1Bup-regulatesbindingYes0.30
RASGEF1Cup-regulatesbindingYes0.20
RAPGEF5up-regulatesGEFYes0.44
RAPGEF6up-regulatesGEFYes0.33
PTPN11up-regulates activitydephosphorylationYes0.67
DAB2IPdown-regulates activityGAPYes0.49
ZDHHC9up-regulates activitypalmitoylationYes0.40
GOLGA7up-regulates activitypalmitoylationYes0.40
STK19up-regulates activityphosphorylationYes0.31
ARdown-regulates quantitytranscriptionalNo0.28
BCR-ABLup-regulates activity-No0.20
MVDup-regulates quantitystabilizationNo0.20
Downstream Targets of NRAS Signaling:
TargetEffectMechanismDirectScore
RAF1up-regulatesrelocalizationYes0.87
BRAFup-regulates activitybindingYes0.85
PIK3CAup-regulates activitybindingYes0.84
ARAFup-regulatesbindingYes0.83
PIK3CGup-regulatesbindingYes0.72
PI3Kup-regulates activitybindingYes0.68
PIK3CBup-regulatesbindingYes0.67
GLI1up-regulates-No0.29

Section 10: Drug & Pharmacology Data ChEMBL Target Information

Target IDNameType
CHEMBL2079845GTPase NRasSINGLE PROTEIN
CHEMBL4524006RASPROTEIN FAMILY
Targeting Molecules Total ChEMBL Molecules Targeting NRAS: 100+ Molecules by Development Phase:
ChEMBL IDNameTypePhase
CHEMBL279433L-778123 FREE BASESmall moleculePhase 1
CHEMBL2086789-Small molecule0
CHEMBL256963-Small molecule0
CHEMBL3182364-Small molecule0
CHEMBL401633-Small molecule0
(+ many research compounds in development)
Note: Direct NRAS inhibitors have historically been challenging to develop. Recent breakthroughs include:
  • RMC-7977 (tricomplex inhibitor with CypA)
  • Daraxonrasib (RMC-6236) (pan-RAS inhibitor)
  • Multiple compounds targeting mutant-specific NRAS (Q61K, Q61R, Q61L) BindingDB Data Total BindingDB Entries: 409 Pharmacogenomics (PharmGKB)
PharmGKB IDSymbolVIP GeneHas CPIC Guideline
PA31768NRASYesNo
Clinical Relevance:
  • NRAS mutations predict response/resistance to targeted therapies
  • Key biomarker in melanoma, colorectal cancer, AML treatment decisions
  • Mutations associated with resistance to EGFR inhibitors (cetuximab, panitumumab)
  • Affects MEK inhibitor sensitivity

Section 11: Expression Profiles Bgee Expression Summary

AttributeValue
Expression BreadthUbiquitous
Total Present Calls278
Max Expression Score96.10
TOP 30 Tissues by Expression Score
Tissue/Anatomical EntityScoreRankQuality
Gingival epithelium96.101820Gold
Epithelium of nasopharynx95.642030Gold
Amniotic fluid95.622040Gold
Colonic mucosa95.542080Gold
Mucosa of sigmoid colon95.522090Gold
Gingiva95.452120Gold
Esophagus squamous epithelium95.202240Gold
Germinal epithelium of ovary95.022320Gold
Upper leg skin94.532550Gold
Ganglionic eminence93.842870Gold
Parietal pleura93.752910Gold
Tibia93.582990Gold
Visceral pleura93.563000Gold
Ventricular zone93.553010Gold
Adrenal tissue93.503030Gold
Endothelial cell93.023260Gold
Cortical plate93.003270Gold
Trabecular bone tissue92.693410Gold
Islet of Langerhans92.653430Gold
Oral cavity92.573460Gold
Pleura92.483510Gold
Skin of hip92.323580Gold
Palpebral conjunctiva91.973750Gold
Endometrium91.893780Gold
Mammary duct91.723860Gold
Jejunal mucosa91.643900Gold
Rectum91.354030Gold
Bone marrow91.154130Gold
Lower lobe of lung90.974210Gold
Embryo90.954220Gold
TOP 30 Cell Types by Expression
Cell TypeScoreQuality
Secondary oocyte95.63Gold
Oocyte93.13Gold
Endothelial cell93.02Gold
Monocyte92.27Gold
Mononuclear cell92.12Gold
Leukocyte91.94Gold
Buccal mucosa cell89.91Gold
Bronchial epithelial cell87.21Gold
Primordial germ cell (gonad)87.16Gold
Stromal cell of endometrium86.11Gold
Bone marrow cell84.90Gold
Granulocyte84.87Gold
Single-Cell Expression Data Single Cell Expression Atlas (SCXA): Data available
  • Multiple experiments include NRAS expression
  • Expression across diverse cell populations

Section 12: Disease Associations Mendelian/Monogenic Disease Links (GenCC)

DiseaseMONDO/OMIM IDClassificationMOISource
Noonan syndrome 6OMIM:613224DefinitiveADG2P
Noonan syndrome 6OMIM:613224StrongADGenomics England
Noonan syndrome 6OMIM:613224StrongADLabcorp/Invitae
Noonan syndromeORPHANET:648SupportiveADOrphanet
Cardiofaciocutaneous syndromeMONDO:0015280StrongADGenomics England
AD = Autosomal Dominant Orphanet Disease Associations (7 total)
Orphanet IDDisease NameTypeGene Count
648Noonan syndromeMalformation syndrome15
86834Juvenile myelomonocytic leukemiaDisease6
268114RAS-associated autoimmune leukoproliferative diseaseDisease2
389Langerhans cell histiocytosisDisease3
626Large/giant congenital melanocytic nevusDisease7
2612Linear nevus sebaceus syndromeDisease3
146Differentiated thyroid carcinomaDisease29
HPO Phenotype Associations Total Associated Phenotypes: 244 TOP 50 Phenotype Terms:
HPO IDPhenotype
HP:0000006Autosomal dominant inheritance
HP:0001249Intellectual disability
HP:0001263Global developmental delay
HP:0001252Hypotonia
HP:0001290Generalized hypotonia
HP:0001250Seizure
HP:0000256Macrocephaly
HP:0000316Hypertelorism
HP:0000508Ptosis
HP:0000465Webbed neck
HP:0000470Short neck
HP:0000767Pectus excavatum
HP:0000768Pectus carinatum
HP:0001382Joint hypermobility
HP:0000957Cafe-au-lait spot
HP:0001004Lymphedema
HP:0000347Micrognathia
HP:0000494Downslanted palpebral fissures
HP:0000486Strabismus
HP:0000369Low-set ears
HP:0000337Broad forehead
HP:0000348High forehead
HP:0000325Triangular face
HP:0000311Round face
HP:0000293Full cheeks
HP:0000218High palate
HP:0000750Delayed speech and language development
HP:0001156Brachydactyly
HP:0000028Cryptorchidism
HP:0000995Melanocytic nevus
HP:0001003Multiple lentigines
HP:0000238Hydrocephalus
HP:0001028Hemangioma
HP:0000978Bruising susceptibility
HP:0000639Nystagmus
HP:0001270Motor delay
HP:0001324Muscle weakness
HP:0001347Hyperreflexia
HP:0000968Eczematoid dermatitis
HP:0000826Precocious puberty
HP:0000545Myopia
HP:0000407Sensorineural hearing impairment
HP:0000365Hearing impairment
HP:0001987Placenta abnormality
HP:0000476Cystic hygroma
HP:0001195Single umbilical artery
HP:0000044Hypogonadotropic hypogonadism
HP:0000998Hypertrichosis
HP:0001054Numerous nevi
HP:0000589Coloboma
GWAS Associations (4 studies)
Study IDTraitP-valueMapped Gene
GCST010988_371Adult body size7.0×10⁻¹⁰NRAS
GCST002268_1Autism3.0×10⁻⁸CSDE1; AMPD1
GCST002268_10Autism4.0×10⁻⁸AMPD1
GCST002268_2Autism9.0×10⁻⁸CSDE1; AMPD1
Cancer Associations (Somatic Mutations) NRAS is one of the most frequently mutated oncogenes. Key cancer types with NRAS mutations:
Cancer TypeMutation Frequency
Melanoma15-25%
Acute Myeloid Leukemia (AML)10-15%
Colorectal Cancer3-5%
Thyroid Cancer5-10%
Multiple Myeloma20-25%
Juvenile Myelomonocytic Leukemia (JMML)15-20%
Hotspot Mutations:
  • G12 (codons 12): G12D, G12S, G12C, G12A, G12V
  • G13 (codon 13): G13D, G13R, G13V
  • Q61 (codon 61): Q61R, Q61K, Q61L, Q61H (most common in melanoma) SUMMARY STATISTICS
CategoryCount
Ensembl Transcripts4
RefSeq Transcripts (Human)2 (NM/NP)
CCDS IDs1
Exons (canonical)7
UniProt Entries2
InterPro Domains4
PDB Structures29
Orthologs (key species)3
Paralogs (human)35
ClinVar Variants330
Pathogenic/Likely Pathogenic20
SpliceAI Predictions577
AlphaMissense Predictions1,251
Reactome Pathways68
GO Terms16
STRING Interactions6,520+
BioGRID Interactions914
IntAct Interactions160
SIGNOR Interactions23
ChEMBL Targeting Molecules100+
BindingDB Entries409
HPO Phenotypes244
GWAS Associations4
Orphanet Diseases7
GenCC Disease-Gene Relations5
Bgee Expression Calls278
Data Sources: HGNC, Ensembl, NCBI Entrez, UniProt, OMIM, RefSeq, CCDS, PDB, AlphaFold, InterPro, Pfam, ClinVar, AlphaMissense, SpliceAI, Reactome, Gene Ontology, STRING, BioGRID, IntAct, SIGNOR, ChEMBL, BindingDB, PharmGKB, Bgee, HPO, Orphanet, GenCC, GWAS Catalog Generated: 2026-03-27 via Biobtree cross-database mapping